Idarubicin Injection 10 mg/10 mL (4)

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

idarubicin hydrochloride, Quantity: 1 mg/mL

Inapatikana kutoka:

Pfizer (Perth) Pty Ltd

Dawa fomu:

Injection, solution

Tungo:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Njia ya uendeshaji:

Intravenous, Intravenous Infusion

Vitengo katika mfuko:

1 x 10 mL

Dawa ya aina:

(S1) This Schedule is intentionally blank

Matibabu dalili:

Zavedos is used to treat acute myeloid and lymphoid leukaemia (types of blood cancer) in adults and children. Zavedos may be administered as a monotherapy or as part of combination therapy (with cytarabine).

Bidhaa muhtasari:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Idhini hali ya:

Listed (Export Only)

Idhini ya tarehe:

2023-03-03